Local Infiltration Analgesia vs Adductor Canal Block for Analgesia After Anterior Cruciate Ligament Reconstruction

May 4, 2018 updated by: Eric Albrecht, Centre Hospitalier Universitaire Vaudois

Postoperative Analgesic Efficacy of Local Infiltration Analgesia Versus Adductor Canal Block After Anterior Cruciate Ligament Reconstruction: A Randomised Controlled Double-blinded Trial

Early rehabilitation after anterior cruciate ligament reconstruction is of paramount importance and requires optimal pain control based on a multimodal concept, including injection of local anaesthetics. Regarding this latter, different options have emerged recently such as the adductor canal block, performed before the surgery by the anaesthesiologist or the infiltration of the articulation performed by the surgeon at the of the intervention. No trial has compared these two approaches. As practice of medicine should be based on evidence, we decided to undertake this randomised controlled trial where we compared the adductor canal block with the local infiltration analgesia technique in terms of pain and functional outcomes

Study Overview

Detailed Description

Patients scheduled to undergo anterior cruciate ligament reconstruction under general anaesthesia will be randomly allocated to two groups: local infiltration analgesia or adductor canal block.

The local infiltration analgesia will be performed by the surgeon at the end of surgery with 20 mLs of ropivacaine 0.5%. The adductor canal block will be performed by the anaesthesiologist under ultrasound guidance after the surgery, before awaking the patient, using the same solution (20 mLs ropivacaine 0.5%)

Postoperative analgesia will include intravenous patient-controlled analgesia of morphine (settings 1 mg/ml, 2 ml/10 minutes, 40 mg/4 hours), ibuprofen (3x400 mg) and acetaminophen (4x1000 mg).

A research assistant and a physiotherapist, both blinded to the group allocation, will collect pain and rehabilitation data, respectively.

Study Type

Interventional

Enrollment (Actual)

104

Phase

  • Phase 4

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Vaud
      • Lausanne, Vaud, Switzerland, 1011
        • Department of Anesthesia, Centre Hospitalier Universitaire Vaudois and University of Lausanne

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 50 years (Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • patients from 18 to 50 years old scheduled to undergo anterior cruciate ligament reconstruction

Exclusion Criteria:

  • peripheral neuropathy
  • pre-existing femoral neuropathy
  • diabetes mellitus
  • alcoholism
  • drug addiction
  • cancer with chemotherapy
  • chronic pain state

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Triple

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Local infiltration analgesia
Infiltration of the knee by the surgeon with local anaesthetics under general anaesthesia.
Injection of the local anesthetic at the end of surgery, either in the surgical sites by the surgeon, or in the adductor canal block by the anesthesiologist under ultrasound guidance.
Other Names:
  • Naropine, Naropin
Active Comparator: Adductor canal block
Injection of local anaesthetics under ultrasound guidance in the adductor canal by the anaesthesiologist after the surgery, before awaking the patient.
Injection of the local anesthetic at the end of surgery, either in the surgical sites by the surgeon, or in the adductor canal block by the anesthesiologist under ultrasound guidance.
Other Names:
  • Naropine, Naropin

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
Total morphine consumption (mg)
Time Frame: 24 h postoperatively
24 h postoperatively

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Total morphine consumption (mg)
Time Frame: 2 h postoperatively
2 h postoperatively
Total morphine consumption (mg)
Time Frame: 48 h postoperatively
48 h postoperatively
Total morphine consumption (mg)
Time Frame: 72 h postoperatively
72 h postoperatively
Pain scores (numeric rating scale, 0-10) at rest and on movement
Time Frame: 2 h postoperatively
2 h postoperatively
Pain scores (numeric rating scale, 0-10) at rest and on movement
Time Frame: 12 h postoperatively
12 h postoperatively
Pain scores (numeric rating scale, 0-10) at rest and on movement
Time Frame: 24 h postoperatively
24 h postoperatively
Pain scores (numeric rating scale, 0-10) at rest and on movement
Time Frame: 36 h postoperatively
36 h postoperatively
Pain scores (numeric rating scale, 0-10) at rest and on movement
Time Frame: 48 h postoperatively
48 h postoperatively
Pain scores (numeric rating scale, 0-10) at rest and on movement
Time Frame: 60 h postoperatively
60 h postoperatively
Pain scores (numeric rating scale, 0-10) at rest and on movement
Time Frame: 72 h postoperatively
72 h postoperatively
Postoperative nausea and vomiting (yes/no)
Time Frame: 24 h postoperatively
24 h postoperatively
Postoperative nausea and vomiting (yes/no)
Time Frame: 48 h postoperatively
48 h postoperatively
Postoperative nausea and vomiting (yes/no)
Time Frame: 72 h postoperatively
72 h postoperatively
Pruritus (yes/no)
Time Frame: 24 h postoperatively
24 h postoperatively
Pruritus (yes/no)
Time Frame: 48 h postoperatively
48 h postoperatively
Pruritus (yes/no)
Time Frame: 72 h postoperatively
72 h postoperatively
Active flexion
Time Frame: 24 h postoperatively
Flexion of the knee by the patient measured in degrees
24 h postoperatively
Active flexion
Time Frame: 48 h postoperatively
Flexion of the knee by the patient measured in degrees
48 h postoperatively
Active flexion
Time Frame: 72 h postoperatively
Flexion of the knee by the patient measured in degrees
72 h postoperatively
Quadriceps muscle strength (numeric scale, 1-5)
Time Frame: 24 h postoperatively
24 h postoperatively
Quadriceps muscle strength (numeric scale, 1-5)
Time Frame: 48 h postoperatively
48 h postoperatively
Quadriceps muscle strength (numeric scale, 1-5)
Time Frame: 72 h postoperatively
72 h postoperatively
Distance walked (meters)
Time Frame: 24 h postoperatively
24 h postoperatively
Distance walked (meters)
Time Frame: 48 h postoperatively
48 h postoperatively
Distance walked (meters)
Time Frame: 72 h postoperatively
72 h postoperatively
Anterior Cruciate Ligament - Return to Sport after Injury scale
Time Frame: 4 months postoperatively
4 months postoperatively
Anterior cruciate ligament -Return to Sport after Injury scale
Time Frame: 8 months postoperatively
8 months postoperatively
International Knee Documentation Committee score
Time Frame: 4 months postoperatively
4 months postoperatively
International Knee Documentation Committee score
Time Frame: 8 months postoperatively
8 months postoperatively

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Eric Albrecht, PD Dr, CHUV

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

September 1, 2015

Primary Completion (Actual)

March 1, 2018

Study Completion (Actual)

March 1, 2018

Study Registration Dates

First Submitted

August 6, 2015

First Submitted That Met QC Criteria

August 13, 2015

First Posted (Estimate)

August 17, 2015

Study Record Updates

Last Update Posted (Actual)

May 7, 2018

Last Update Submitted That Met QC Criteria

May 4, 2018

Last Verified

May 1, 2018

More Information

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Regional Anesthesia Morbidity

Clinical Trials on Ropivacaine 0.5% 20 mLs

Subscribe